MarinHealth makes waves with first AI-driven aneurysm repair: A new era in vascular surgery
MarinHealth has made headlines with its groundbreaking use of augmented artificial intelligence for aneurysm repair, marking a significant advancement in vascular surgery. The healthcare provider ... Read More
GRAIL’s new REACH study of Galleri MCED test set to change future of cancer detection for seniors – Find out how
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company renowned for its mission to detect cancer early when it can be effectively treated, has announced a significant ... Read More
AI revolution in lung disease care: Brainomix and Boehringer Ingelheim forge game-changing partnership
Brainomix, a leader in artificial intelligence (AI) imaging solutions, has announced a partnership with the German pharmaceutical giant Boehringer Ingelheim. This collaboration aims to enhance ... Read More
Octagos Health secures $43m in Series B to enhance AI-driven cardiac care
Octagos Health, a trailblazer in AI-driven cardiac device monitoring, has successfully raised over $43 million in a Series B funding round. The investment was spearheaded ... Read More
FDA approves Roche’s Vabysmo prefilled syringe for eye diseases, expanding treatment options for millions
Roche (SIX: RO, ROG; OTCQX: RHHBY), a global leader in pharmaceuticals and diagnostics, announced a significant advancement in eye care with the U.S. Food and ... Read More
Johnson & Johnson’s TB drug SIRTURO receives full approval from FDA and EC
In a significant development for the treatment of drug-resistant tuberculosis (TB), Johnson & Johnson has announced that SIRTURO (bedaquiline) has received full approval from the ... Read More
FDA approves Eli Lilly’s Kisunla for Alzheimer’s treatment
The U.S. Food and Drug Administration (FDA) has approved Kisunla (donanemab-azbt), an Alzheimer's treatment developed by Eli Lilly and Company (NYSE: LLY). This treatment, specifically ... Read More
Amsino Medical Group partners with Novo Tellus for strategic investment to enhance global medical supply
Amsino Medical Group, a prominent global provider of medical consumable devices, has successfully concluded a significant equity investment from Novo Tellus, a leading investment firm ... Read More
Eli Lilly and OpenAI forge pioneering alliance to combat antimicrobial resistance
Eli Lilly and Company (NYSE: LLY) has entered into a partnership with OpenAI to harness generative AI for the discovery of new antimicrobials, aiming to ... Read More
Zynext Ventures invests in Promaxo’s innovative MRI and robotic technologies
Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has made a significant investment in Promaxo Inc., a leading developer of portable low-field ... Read More